文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

神经元 NLRP3 是帕金森病中驱动神经退行性变的 parkin 底物。

Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.

机构信息

Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Diana Helis Henry Medical Research Foundation, New Orleans, LA 70130, USA.

出版信息

Neuron. 2022 Aug 3;110(15):2422-2437.e9. doi: 10.1016/j.neuron.2022.05.009. Epub 2022 Jun 1.


DOI:10.1016/j.neuron.2022.05.009
PMID:35654037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9357148/
Abstract

Parkinson's disease (PD) is mediated, in part, by intraneuronal accumulation of α-synuclein aggregates andsubsequent death of dopamine (DA) neurons in the substantia nigra pars compacta (SNpc). Microglial hyperactivation of the NOD-like receptor protein 3 (NLRP3) inflammasome has been well-documented in various neurodegenerative diseases, including PD. We show here that loss of parkin activity in mouse and human DA neurons results in spontaneous neuronal NLRP3 inflammasome assembly, leading to DA neuron death. Parkin normally inhibits inflammasome priming by ubiquitinating and targeting NLRP3 for proteasomal degradation. Loss of parkin activity also contributes to the assembly of an active NLRP3 inflammasome complex via mitochondrial-derived reactive oxygen species (mitoROS) generation through the accumulation of another parkin ubiquitination substrate, ZNF746/PARIS. Inhibition of neuronal NLRP3 inflammasome assembly prevents degeneration of DA neurons in familial and sporadic PD models. Strategies aimed at limiting neuronal NLRP3 inflammasome activation hold promise as a disease-modifying therapy for PD.

摘要

帕金森病(PD)部分由α-突触核蛋白聚集体在神经元内的积累以及随后的黑质致密部多巴胺(DA)神经元死亡介导。NOD 样受体蛋白 3(NLRP3)炎症小体的小胶质细胞过度激活在各种神经退行性疾病中已有充分记录,包括 PD。我们在这里表明,在小鼠和人类 DA 神经元中 parkin 活性的丧失导致自发性神经元 NLRP3 炎症小体组装,导致 DA 神经元死亡。Parkin 通过泛素化和靶向 NLRP3 进行蛋白酶体降解来正常抑制炎症小体的引发。Parkin 活性的丧失还通过线粒体来源的活性氧(mitoROS)的产生,通过另一种 parkin 泛素化底物 ZNF746/PARIS 的积累,导致活性 NLRP3 炎症小体复合物的组装。抑制神经元 NLRP3 炎症小体组装可防止家族性和散发性 PD 模型中 DA 神经元的退化。旨在限制神经元 NLRP3 炎症小体激活的策略有望成为 PD 的一种疾病修饰治疗方法。

相似文献

[1]
Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.

Neuron. 2022-8-3

[2]
Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease.

Aging Cell. 2023-6

[3]
Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway.

Neuropharmacology. 2024-10-1

[4]
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.

Autophagy. 2019-4-9

[5]
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.

Sci Transl Med. 2018-10-31

[6]
MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.

Cell Death Differ. 2018-5-21

[7]
NLRP3 Inflammasomes in Parkinson's disease and their Regulation by Parkin.

Neuroscience. 2020-10-15

[8]
Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease.

Brain Behav Immun. 2021-1

[9]
p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.

J Neuroinflammation. 2021-12-20

[10]
Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.

Oxid Med Cell Longev. 2020

引用本文的文献

[1]
Polymeric nanoparticle-mediated GBA1 gene therapy is neuroprotective in a preclinical model of Parkinson's disease.

Drug Deliv Transl Res. 2025-8-20

[2]
Protein regulatory network mediated by palmitoylation modifications in the pathological progression of Parkinson's disease: a narrative review.

Front Immunol. 2025-7-9

[3]
Ubiquitination in the Nervous System: From Molecular Mechanisms to Disease Implications.

Mol Neurobiol. 2025-7-15

[4]
Immune Cell Proteins and Parkinson's Disease: A Mendelian Randomization Analysis of Causal Associations.

Brain Behav. 2025-7

[5]
JC124 confers multimodal neuroprotection in epilepsy by suppressing NLRP3 inflammasome activation: evidence from animal and human neuronal models.

Cell Commun Signal. 2025-7-8

[6]
Electroacupuncture alleviates Parkinson's disease by inhibiting the NLRP3 inflammasome pathway.

Am J Transl Res. 2025-5-15

[7]
The role of NLRP3 inflammasome in necrotizing enterocolitis.

Pediatr Res. 2025-6-5

[8]
Lactobacillus reuteri-derived γ-amino butyric acid alleviates MPTP-induced Parkinson's disease through inhibiting ferroptosis via the AKT-GSK3β-GPX4 axis.

NPJ Parkinsons Dis. 2025-6-4

[9]
An update on the involvement of inflammatory mediators in Parkinson's disease pathogenesis.

Arch Toxicol. 2025-6-3

[10]
Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson's disease model.

J Neuroinflammation. 2025-5-17

本文引用的文献

[1]
STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy.

Proc Natl Acad Sci U S A. 2022-4-12

[2]
Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson's disease.

Sci Adv. 2022-4

[3]
Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases.

Acta Pharmacol Sin. 2022-10

[4]
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection.

Pharmacol Rev. 2021-10

[5]
TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.

Neuron. 2021-12-1

[6]
PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease.

Sci Transl Med. 2021-7-28

[7]
Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons.

Stem Cell Reports. 2020-9-8

[8]
Slc6a3-dependent expression of a CAPS-associated Nlrp3 allele results in progressive behavioral abnormalities and neuroinflammation in aging mice.

J Neuroinflammation. 2020-7-17

[9]
AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment.

Nature. 2020-4-8

[10]
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease.

Mol Neurodegener. 2020-3-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索